What EBITDA multiples do home care agencies sell for in 2026?

In 2026, multiples range from 3.5x for agencies under $500K EBITDA to 8x or higher for large platforms. Hospice leads at 6–12x, followed by private duty nursing and skilled home health.

Which home care service line commands the highest EBITDA multiple?

Hospice agencies consistently achieve the highest multiples (6–12x EBITDA), followed by private duty nursing (5–8x) and Medicare-certified skilled home health (4.5–8x).

Are home care M&A multiples still strong in 2026?

Yes. Multiples stabilized after modest compression in 2022–2023 and premium segments like hospice remain near historic highs. Quality assets continue to attract strong buyer interest.

Does geography affect home care agency EBITDA multiples?

Yes. Agencies in high-density metro areas with large aging populations often command a 0.5x–1.0x premium over the national benchmark for comparable businesses.

Home Care Business EBITDA Multiples: 2026 Benchmark Report

Every quarter, we compile transaction data from our active deal flow, third-party M&A research firms, and published industry reports to produce what has become the most widely referenced benchmark dataset in the home care M&A advisory market.

This 2026 benchmark report covers EBITDA multiple ranges by service line, the buyer categories commanding the highest valuations, and the specific factors driving premium outcomes in today’s market.

Executive Summary

2026 is the strongest seller’s market in home care M&A history. The confluence of three dynamics — peak PE capital deployment, demographic tailwinds creating irreversible demand, and post-COVID operational consolidation — has pushed EBITDA multiples to cycle highs across all home care subsectors.

Key data points:

Average home care EBITDA multiple reached 6.2× in 2024, up from 4.8× in 2021 (Scope Research)
Top-quartile home health and hospice agencies are routinely achieving 8–10× EBITDA
PE-backed platforms now represent 62% of buyer-side transactions, up from 41% in 2020
Median time to close for represented sellers: 87 days (vs. 6–12 months for unrepresented)

Multiple Benchmarks by Segment

Non-Medical Personal Care

Multiple Range: 2.0× – 4.5× EBITDA

Non-medical personal care — homemaker, companion, and personal assistance services — remains the largest volume segment in home care M&A but trades at the lowest multiples due to its Medicaid-heavy payer mix and lower margin profile.

Premium outcomes (3.5–4.5×) are achievable for agencies with:

Strong private-pay or managed care mix (30%+ non-Medicaid revenue)
Caregiver retention above 75%
Formal management structure
Multiple geographies or a territory expansion story for the buyer

Medicare-Certified Home Health

Multiple Range: 3.5× – 7.0× EBITDA

Medicare home health agencies continue to attract significant PE and strategic buyer interest. Medicare reimbursement is federal, relatively predictable, and highly strategically valuable to health systems and payers building integrated home-based care models. The move to PDGM (Patient-Driven Groupings Model) reimbursement has separated operationally sophisticated agencies from weaker operators, driving a flight to quality in buyer preferences.

Premium outcomes (5.5–7.0×) are achievable for agencies with:

Strong OASIS scores and star ratings (quality of care indicators)
10+ year operational history
Geographic coverage in high-demand markets
Multiple Medicare specialty programs (wound care, cardiac, etc.)
Strong physician and hospital referral relationships

Hospice

Multiple Range: 5.0× – 9.0× EBITDA

Hospice commands the highest multiples in home care M&A due to its per-diem Medicare reimbursement structure, among the highest EBITDA margins in healthcare (20–35%), and the relative stability of its revenue base. PE and health system interest in hospice has accelerated dramatically — hospice assets representing the most competitive bidding environment in the entire home care sector.

Premium outcomes (7.0–9.0×) are achievable for agencies with:

80%+ Medicare hospice revenue
ADC (Average Daily Census) above 100
Clean PEPPER reports and no outstanding CMS audits
GIP (General Inpatient) and Residential capabilities
Strong physician relationships and referral network

Multi-Service Platforms

Multiple Range: 6.0× – 10×+ EBITDA

Multi-service platforms — agencies offering two or more service lines, typically at $3M+ EBITDA — command the highest absolute multiples in the market. Buyers pay a “platform premium” because multi-service agencies represent turnkey geographic market entry, diversified revenue streams, and a built-in management infrastructure.

For PE platforms executing a buy-and-build strategy, acquiring a quality multi-service platform can accelerate their regional consolidation thesis by 2–3 years. This scarcity premium pushes multiples above 8× for the strongest assets.

Who’s Buying and What They’re Paying

Understanding the buyer landscape is essential for sellers and their advisors to build the right competitive process.

Private Equity Platforms (Pay: 5–10×)

80+ PE-backed home care platforms are actively acquiring. Key characteristics:

Move quickly when quality assets are presented
Have committed capital ready to deploy
Pay premium prices for assets that fit their geographic or service-line thesis
Aggressive on price when competing with other PE buyers
Require clean financials, operational controls, and management continuity

Regional Strategic Operators (Pay: 4–7×)

200+ regional home care companies seek geographic expansion. Key characteristics:

Faster, less complex diligence than PE
Strong cultural fit with sellers (both operational companies)
Often willing to retain existing management and brand
Less aggressive on price in direct negotiations, but competitive in a structured process

National Consolidators / Health Systems (Pay: 6–10×)

Humana, Optum/UnitedHealth, CVS/Aetna, and large health systems are building integrated home-based care platforms. Key characteristics:

Highest absolute prices for scale assets ($10M+ revenue)
Complex procurement process and longer timeline
Require Medicare certification, quality metrics, and geographic scale
Often pay above market for strategic fit (e.g., a geography they need to complete their coverage map)

What’s Driving the Premium Environment

Three structural forces explain why 2026 multiples are at cycle highs:

1. PE Capital Deployment Pressure Private equity firms raised a record $1.2T+ in dry powder in 2023–2024. Fund managers with committed capital on 10-year fund timelines face pressure to deploy — and home care represents one of the most attractive healthcare services subsectors for risk-adjusted returns.

2. Demographic Tailwinds By 2030, all 73 million Baby Boomers will be over 65. Adults over 85 — the heaviest users of home care services — will represent 6% of the U.S. population by 2040 (U.S. Census Bureau). This demographic wave is non-cyclical, largely non-discretionary, and creates a 15–20 year structural demand tailwind that buyers are pricing into their acquisition thesis.

3. Supply-Side Consolidation The home care sector is still highly fragmented — 80%+ of agencies have annual revenue below $3M. As operational complexity increases (workforce regulations, technology requirements, payer contracting), independent operators face growing pressure, increasing both the supply of sellers and the strategic premium buyers place on quality assets.

The Window Won’t Stay Open Forever

Market cycles are real. Interest rates, PE fund deployment phases, and regulatory shifts all influence home care M&A valuations. The current multiple expansion has been extraordinary — and while structural factors suggest a sustained strong market, the 2024–2026 window of maximum competition and maximum multiples will not persist indefinitely.

Owners who go to market in 2026 — positioned correctly, with the right representation, into a competitive buyer process — are capturing exits they couldn’t have achieved two years ago.

Book a confidential call with Neli Gertner to discuss your timing, your goals, and your options.